2型糖尿病の防止および処置において使用することができる医薬品を調製するためのリモナバントの使用

Title:

2型糖尿病の防止および処置において使用することができる医薬品を調製するためのリモナバントの使用

Document Type and Number:

Japanese Patent JP2008530189

Kind Code:

A

Abstract:

Use of rimonabant and N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide, as cannabinoids (CB1) receptor antagonists (I), for the preparation of drugs useful to treat and prevent type-II diabetes. An independent claim is included for a composition comprising (I) and an active ingredient of metformin and sulfonylurea. ACTIVITY : Antidiabetic. MECHANISM OF ACTION : Cannabinoids (CB1) receptor antagonist.

More Like This:

WO/2005/065455	IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
WO/2007/006790	COMBINATION OF A DPP-IV INHIBITOR AND A CANNABINOID CB1 RECEPTOR ANTAGONIST
WO/2019/217822	COMPOUNDS AND METHODS OF USING COMPOUNDS FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY CONDITIONS

Inventors:

Anotan, Corinne
Lauzan's waig, pierre

Application Number:

JP2007555669A

Publication Date:

August 07, 2008

Filing Date:

February 20, 2006

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Sanofui-Aventice

International Classes:

A61K31/454; A61K31/155; A61K45/00; A61P3/10; A61P9/00; A61P25/02; A61P27/02; C07D231/14

Attorney, Agent or Firm:

Yoshio Kawaguchi
Makoto Ono
Chihiro Watanabe
Kenkyo Kanayama
Katsuma Osaki
Mitsuaki Tsubokura

Previous Patent: （１，５−ジフェニル−１Ｈ−ピラゾール−３−イル）オキサジアゾール�...

Next Patent: 化学物質